Clinical Trials Directory

Trials / Unknown

UnknownNCT01958697

Age and Gender Corrected Body Mass Index

Age and Gender Corrected Body Mass Index: When Preoperative Weight Loss and Underweight Are Becomming Clinically Significant in Esophagectomy for Cancer.

Status
Unknown
Phase
Study type
Observational
Enrollment
650 (estimated)
Sponsor
University Hospital, Gasthuisberg · Academic / Other
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Not accepted

Summary

Esophagectomy for cancer is often accompanied with severe preoperative weight loss. Body Mass Index (BMI) values are age-independent and the same for both sexes. From the perspective that these two parameters should actually be taken into account too, we developed a model to calculate "age-gender specific BMI-percentiles" (AG-BMI) and tested this model in relation to survival outcome after esophagectomy for cancer.

Detailed description

Age-Gender specific BMI percentiles are more accurate compared to the current BMI classes in predicting Overall Survival (OS) after esophagectomy for cancer. Furthermore we believe in a more devastating impact on OS from underweight and not from overweight. By preoperatively identifying risk patients for poorer OS, especially the non-tumoral deaths, this can be a tool to tailor postoperative nutritional strategies to counter further weight loss and bringing postoperative weight to normal ranges.

Conditions

Timeline

Start date
2013-07-01
Primary completion
2013-10-01
Completion
2014-06-01
First posted
2013-10-09
Last updated
2013-10-09

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01958697. Inclusion in this directory is not an endorsement.

Age and Gender Corrected Body Mass Index (NCT01958697) · Clinical Trials Directory